H1N1 (Swine Flu) Vaccine Product: Alphavax and GSK
Alphavax, of Research Triangle Park, reported completing preclinical work and is developing product for clinical trials of its H1N1 (Swine Flu) vaccine, per company press release (click here).
GlaxoSmithKline (GSK) tasks order for 195 million doses of vaccine
The Times (UK) click here
GlaxoSmithKline (GSK) tasks order for 195 million doses of vaccine
The Times (UK) click here
Labels: clinical trial, clinical trials, H1N1, infectious disease, influenza
posted by Anthony Risser at 3:57 PM
0 Comments:
Post a Comment
<< Home